Delivery Order SPE2DB25D3504-SPE2DB25FVWHA
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Doxepin HCL 3 MG Tablets in packages of 30. The $1,795.44 contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous federal contracts from DLA to supply pharmaceuticals and medical supplies for military treatment programs and facilities....
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $6,829.72 order is for the supply of 3 mg doxepin hydrochloride tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of doxepin hydrochloride 3 mg tablets, a medication used to treat certain mental health conditions. The contract has a firm fixed price of $11,201.31 and an ultimate completion date of November 1, 2023. This delivery order is part of a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568603966 - Doxepin HCL 3 MG Tablet 30S, with a ceiling value of $1,038.16. The contract is a firm fixed-price delivery order and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,878.60, is for the delivery of doxepin hydrochloride 3 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through May 28, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution services company. The contract is for the delivery of 4564074174 - Doxepin HCL 3 MG Tablet 30S, a pharmaceutical product, with a ceiling value of $1,494.70 and a period of performance through March 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Doxepin HCL 6 mg tablets, a medication used to treat mental health conditions. The contract has a total ceiling value of $5,189.06 and runs through May 14, 2024. It is a firm fixed price contract with no set-aside designation, indicating open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $12,520.40 firm fixed-price contract is for the provision of Doxepin HCl 6 mg tablets and has a performance period through February 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,430.46 firm fixed-price delivery order is for the supply of Doxepin HCL 3 mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023 with no set-aside designation,...
- This federal contract award, valued at $10,367.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Doxepin HCL 3 mg tablets in quantities of 30s. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWHADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Doxepin HCL 3 mg tablets (30-count units) with a ceiling value of $1,102.17. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and has an ultimate completion date of September 12, 2025. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA supply chain. The company maintains an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, including neurological, pain management, diabetes, and antibiotic treatments. The IDC vehicle under which this delivery order falls supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally, positioning AmerisourceBergen as a key provider within the DLA's Pharmaceutical Prime Vendor program supporting military medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/11/25 |